Carlyle-backed Pathology Firm Metropolis plans Fund Raise via IPO

Pathology chain operator Metropolis Healthcare Ltd is eyeing to raise around Rs 1,500 crore ($230 million) through an initial share sale.

Ameera Shah, managing director and CEO of Metropolis Healthcare said the IPO will likely include a partial stake sale by the Shah family, besides fresh equity.

The proceeds from the stake sale by the founders will be used to repay the loan taken to buy out a private equity investor about three years ago, the report said, adding part of the fund raised through the IPO will also be used for acquisitions.

In 2015, the Shah family had bought back the entire 27% stake held by private equity major Warburg Pincus in Metropolis Healthcare for an undisclosed amount.